Showing results (1051-1060 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|February 19, 2016
A single test for rejecting the null hypothesis in subgroups and in the overall sampleYunzhi Lin, Kefei Zhou, Jitendra GanjuJournal of Biopharmaceutical Statistics|February 20, 2016
Continuous endpoints in Bayesian two-stage designsPierpaolo Brutti, Fulvio De Santis, Stefania Gubbiotti, et al.Journal of Biopharmaceutical Statistics|January 27, 2025
Bayesian design of clinical trials with multiple time-to-event outcomes subject to functional cureSeoyoon Cho, Matthew A Psioda, Joseph G IbrahimJournal of Biopharmaceutical Statistics|January 24, 2025
Bayesian efficient safety monitoring: a simple and well-performing framework to continuous safety monitoring of adverse events in randomized clinical trialsLiangcai Zhang, Ming Chen, Vladimir Dragalin, et al.Journal of Biopharmaceutical Statistics|January 20, 2025
A Bayesian joint bent-cable model for longitudinal measurements and survival time with heterogeneous random-effects distributionsOludare Ariyo, Kehinde Olobatuyi, Taban BaghfalakiJournal of Biopharmaceutical Statistics|November 25, 2024
The 2009 FDA PRO guidance, Potential Type I error, Descriptive Statistics and Pragmatic estimation of the number of interviews for item elicitationJosh Fleckner, Chris BarkerJournal of Biopharmaceutical Statistics|December 21, 2024
Applying machine learning-based multiple imputation methods to nonparametric multiple comparisons in longitudinal clinical studiesTuncay Yanarateş, Erdem KarabulutJournal of Biopharmaceutical Statistics|December 19, 2024
On a Holm-related MTP for rejecting at least k hypotheses: general validity, optimality property, confidence regions, and applicationsOlivier J M GuilbaudJournal of Biopharmaceutical Statistics|December 9, 2024
Borrowing using historical-bias power prior with empirical BayesHsin-Yu Lin, Elizabeth SlateJournal of Biopharmaceutical Statistics|November 17, 2024
Machine learning approach for detection of MACE events within clinical trial dataJohn A Spanias, Robbie Buderi, Pierre-Louis Bourlon, et al.Pageof 216